ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,440,572, issued on Oct. 14, was assigned to ZHENGZHOU GENSCIENCES INC. (Zhengzhou, China).
"FVIII fusion protein and use thereof" was invented by Hongsheng Su (Beijing), Xiaoshan Wang (Beijing), Bin Liu (Beijing), Xian Chen (Beijing), Xiang Li (Beijing), Luyan Zhu (Beijing), Shuya Wang (Kaifeng, China), Shuang Wang (Beijing), Wenwen Wang (Kaifeng, China), Lingli Huang (Kaifeng, China), Qilei Wang (Kaifeng, China), Haitao Hu (Kaifeng, China), Lili Zhang (Kaifeng, China), Jie Gao (Kaifeng, China), Zijia Ren (Kaifeng, China), Chunfeng Xiao (Beijing) and Yali Wang (Beijing).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are a coagulation factor VII...